EPIC Program Annual Data Tables 2008-2009 Appendix: Table VII

Table VII
Ten Most Frequently Purchased Types of Drugs
by Therapeutic Classification^*

Therapeutic Class**	Number of Claims	Percent of Claims	EPIC  Payments	Number of Participants
Total***	4,408,504	43.52%	$137,160,498
BETA-ADRENERGIC BLOCKING AGENT	780,322	7.69%	$8,456,584	146,638
HMG-COA REDUCTASE INHIBITORS	717,024	7.08%	$30,493,147	152,200
PROTON-PUMP INHIBITORS	450,506	4.45%	$36,312,551	95,289
ANGIOTENSIN-CONVERTING ENZYME	445,270	4.40%	$2,850,530	92,004
ANTIDEPRESSANTS	371,831	3.67%	$9,778,448	66,394
ANGIOTENSIN II RECEPTOR ANTAGO	371,332	3.67%	$20,245,725	73,090
DIHYDROPYRIDINES	361,158	3.57%	$6,657,857	72,191
THYROID AGENTS	316,485	3.12%	$2,016,283	58,703
OPIATE AGONISTS	309,117	3.05%	$6,486,375	80,038
BETA-ADRENERGIC AGONISTS	285,459	2.82%	$13,862,998	46,261

^* Table VII provides the percent of adjudicated claims for the program year (October 1, 2008 through September 30, 2009) as they fall into particular categories of Therapeutic Class.

^** American Hospital Formulary Service® (AHFS) Pharmacologic-Therapeutic Classification.

^*** This report contains the top ten drug classes; additional drug classes comprise the remainder of claims up to 100.00%.